These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37500333)

  • 1. Indole metabolites generated by microbiota inhibit Cryptosporidium growth.
    Mead JR
    Trends Parasitol; 2023 Sep; 39(9):716-717. PubMed ID: 37500333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota-produced indole metabolites disrupt mitochondrial function and inhibit Cryptosporidium parvum growth.
    Funkhouser-Jones LJ; Xu R; Wilke G; Fu Y; Schriefer LA; Makimaa H; Rodgers R; Kennedy EA; VanDussen KL; Stappenbeck TS; Baldridge MT; Sibley LD
    Cell Rep; 2023 Jul; 42(7):112680. PubMed ID: 37384526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome-Metabolomics Analysis of the Impacts of
    Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
    Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota produced indole metabolites disrupt host cell mitochondrial energy production and inhibit
    Funkhouser-Jones LJ; Xu R; Wilke G; Fu Y; Shriefer LA; Makimaa H; Rodgers R; Kennedy EA; VanDussen KL; Stappenbeck TS; Baldridge MT; Sibley LD
    bioRxiv; 2023 May; ():. PubMed ID: 37292732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
    VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
    mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptosporidiosis Drug Discovery: Opportunities and Challenges.
    Manjunatha UH; Chao AT; Leong FJ; Diagana TT
    ACS Infect Dis; 2016 Aug; 2(8):530-7. PubMed ID: 27626293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in genetic manipulation of Cryptosporidium.
    Vinayak S
    Curr Opin Microbiol; 2020 Dec; 58():146-152. PubMed ID: 33161368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic parasite revealed improved prospects for treatment and control of human cryptosporidiosis through advanced technologies.
    Jex AR; Smith HV; Nolan MJ; Campbell BE; Young ND; Cantacessi C; Gasser RB
    Adv Parasitol; 2011; 77():141-73. PubMed ID: 22137584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection.
    Chappell CL; Darkoh C; Shimmin L; Farhana N; Kim DK; Okhuysen PC; Hixson J
    Infect Immun; 2016 Aug; 84(8):2299-306. PubMed ID: 27245413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research progress on nutrient transport and metabolism of Cryptosporidium].
    Wang JH; Xue XH; Li PY
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Dec; 28(6):451-4. PubMed ID: 21500534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minireview: clinical cryptosporidiosis.
    Chalmers RM; Davies AP
    Exp Parasitol; 2010 Jan; 124(1):138-46. PubMed ID: 19545516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoproteins and Gal-GalNAc cause Cryptosporidium to switch from an invasive sporozoite to a replicative trophozoite.
    Edwinson A; Widmer G; McEvoy J
    Int J Parasitol; 2016 Jan; 46(1):67-74. PubMed ID: 26432292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Cryptosporidium parvum infection on intestinal fungal microbiota in yaks (Bos grunniens).
    Lu S; Zou W; Chen X; Sun G; Cidan Y; Almutairi MH; Dunzhu L; Nazar M; Mehmood K; Zhu Y; Basang W; Li K
    Microb Pathog; 2023 Oct; 183():106322. PubMed ID: 37633503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptosporidium: host and parasite transcriptome in infection.
    Relat RMB; O'Connor RM
    Curr Opin Microbiol; 2020 Dec; 58():138-145. PubMed ID: 33160225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cultivation of Cryptosporidium parvum and screening for anticryptosporidial drugs.
    McDonald V; Stables R; Warhurst DC; Barer MR; Blewett DA; Chapman HD; Connolly GM; Chiodini PL; McAdam KP
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1498-500. PubMed ID: 2221857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary environmental factors shape the immune defense against Cryptosporidium infection.
    Maradana MR; Marzook NB; Diaz OE; Mkandawire T; Diny NL; Li Y; Liebert A; Shah K; Tolaini M; Kváč M; Stockinger B; Sateriale A
    Cell Host Microbe; 2023 Dec; 31(12):2038-2050.e4. PubMed ID: 38052207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cryptosporidiosis. Characterization of a new infection with special regard to water as the source of infection].
    Exner M; Gornik V
    Zentralbl Hyg Umweltmed; 1990 May; 190(1-2):13-25. PubMed ID: 2203371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling of faecal extracts from Cryptosporidium parvum infection in experimental mouse models.
    Ng Hublin JS; Ryan U; Trengove R; Maker G
    PLoS One; 2013; 8(10):e77803. PubMed ID: 24204976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity in mitochondrial metabolic pathways in parasitic protists Plasmodium and Cryptosporidium.
    Mogi T; Kita K
    Parasitol Int; 2010 Sep; 59(3):305-12. PubMed ID: 20433942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megasphaera in the Stool Microbiota Is Negatively Associated With Diarrheal Cryptosporidiosis.
    Carey MA; Medlock GL; Alam M; Kabir M; Uddin MJ; Nayak U; Papin J; Faruque ASG; Haque R; Petri WA; Gilchrist CA
    Clin Infect Dis; 2021 Sep; 73(6):e1242-e1251. PubMed ID: 33684930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.